VINCIARELLI PATRIZIO sold $6.1M of VICR

VINCIARELLI PATRIZIO (Chairman & CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $304.87 ($296.12–$309.20, $6.10M total) across 13 trades on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 16, 2026, 5:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 5:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The newest concrete information is the disclosed open-market sale size (~$6.1M) and the confirmation that it was executed under a pre-arranged Rule 10b5-1 plan.

02

Market read

This is a routine insider-sale disclosure; it may slightly affect sentiment but is unlikely to change valuation without additional company-specific catalysts.

03

What to watch

Traders may overreact to insider sales; the key nuance here is the 10b5-1 pre-arrangement and the fact the trades occurred days before filing.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-16; sale executed 2026-06-12.

Background

SEC Form 4 reports an insider transaction by VINCIARELLI PATRIZIO (Chairman & CEO, 10% owner) for VICOR CORP.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s CEO/Chairman sold about $6.1M of VICR shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low probability of a sustained price move solely from this filing; any reaction is likely short-lived.

Evidence & confidence

The filing is a routine insider sale (S code) with stated 10b5-1 plan, reducing interpretive weight versus discretionary selling.

Market effects

No sector-wide implication; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, the disclosure may have minimal informational content and may not warrant a directional trade.

Key entities

  • VICOR CORP

    Company whose shares were sold by its Chairman & CEO via Form 4.

  • VINCIARELLI PATRIZIO

    Chairman & CEO and 10% owner who executed the sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.